title: Haplotype structures and functional polymorphic variants of the drug target enzyme aromatase (CYP19A1) in South Indian population.
abstract: CYP19A1 gene product aromatase (CYP19A1) is a 58-kDa protein and belongs to the member of the cytochrome P450 superfamily, which facilitates the bioconversion of estrogens from androgens. Single-nucleotide polymorphisms (SNPs) of CYP19A1 affect the activity of the enzyme and have been implicated in the association of estrogen-dependent disease, prognosis, therapeutic efficacy, and toxicity of third-generation aromatase inhibitors (AIs). Based on ethnicity, the frequency distribution of CYP19A1 alleles will differ, and until now, no data are available for Indians. Using qRT-PCR with TaqMan assays, the frequencies of functionally important polymorphic variants of CYP19A1 gene were determined in 163 healthy subjects of South Indian origin. The observed frequencies of the CYP19A1 minor alleles for the SNPs rs4646 (T), rs10046 (T), rs700519 (T), rs700518 (G), rs727479 (G), rs4775936 (T), rs10459592 (G), rs749292 (A), rs6493497 (T), and rs7176005 (A) are 41.1 (35.8-46.4), 20.0 (15.6-24.3), 33.7 (28.6-38.9), 17.8 (13.6-21.9), 25.8 (21.0-30.5), 19.9 (15.6-24.3), 33.7 (28.6-38.9), 24.9 (20.2-29.5), 35.9 (30.7-41.1), and 35.9 (30.7-41.1), respectively. Strong linkage disequilibrium existed between CYP19A1 SNPs, and sixteen different haplotype structures with a frequency >1% were derived from all the 10 SNPs tested. The most common being the haplotype (H1) GCTATCTGTG with a frequency of about 17.8%. Gender-specific assessment showed significant difference in the allele frequency for rs749292 (p < 0.04), and greater inter-ethnic variation was detected in the distribution of CYP19A1 variants except for rs727479. Our results could provide preliminary insight for further pharmacogenetic investigations of AIs as well as for subsequent molecular epidemiological studies on the contribution of these variants to the occurrence and development of estrogen-dependent disease in South Indians.
authors.affiliation: ICMR Centre for Advanced Research in Pharmacogenomics, Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry 605006, India. umagenes@gmail.com
authors.forename: Gurusamy
authors.initials: G
authors.lastname: Umamaheswaran
authors.forename: Steven Aibor
authors.initials: SA
authors.lastname: Dkhar
authors.forename: Sekar
authors.initials: S
authors.lastname: Kalaivani
authors.forename: Raj
authors.initials: R
authors.lastname: Anjana
authors.forename: Mohan
authors.initials: M
authors.lastname: Revathy
authors.forename: Mohammad
authors.initials: M
authors.lastname: Jaharamma
authors.forename: Kulumani Mahadevan Lakshmi
authors.initials: KM
authors.lastname: Shree
authors.forename: Dharanipragada
authors.initials: D
authors.lastname: Kadambari
authors.forename: Chandrasekaran
authors.initials: C
authors.lastname: Adithan
mesh_terms: D000328:Adult; D000483:Alleles; D001141:Aromatase / Q000235:genetics*; D044466:Asian People / Q000235:genetics*; D004967:Estrogens / Q000235:genetics; D005260:Female; D006239:Haplotypes / Q000235:genetics*; D006801:Humans; D007194:India; D015810:Linkage Disequilibrium; D008297:Male; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*
chemical_list: D004967:Estrogens; D001141:Aromatase; C561410:CYP19A1 protein, human
references.citation: Neurology. 2004 Apr 13;62(7):1170-6
references.pmid: 15079018
references.citation: J Clin Endocrinol Metab. 2007 Feb;92(2):660-5
references.pmid: 17118999
references.citation: Hum Reprod. 2002 Apr;17(4):897-902
references.pmid: 11925378
references.citation: Breast Cancer Res Treat. 2012 Jun;133(3):1191-8
references.pmid: 22418701
references.citation: Genet Test Mol Biomarkers. 2012 Aug;16(8):835-40
references.pmid: 22731640
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):943-9
references.pmid: 17507620
references.citation: BMC Cancer. 2010 Feb 09;10:36
references.pmid: 20144226
references.citation: Endocr Relat Cancer. 2008 Dec;15(4):1055-60
references.pmid: 18667686
references.citation: Fundam Clin Pharmacol. 2012 Apr;26(2):295-306
references.pmid: 21265876
references.citation: Expert Opin Pharmacother. 2012 Jun;13(9):1299-307
references.pmid: 22594760
references.citation: Breast Cancer Res Treat. 2010 Jul;122(2):495-501
references.pmid: 20052540
references.citation: Endocr Rev. 1994 Jun;15(3):342-55
references.pmid: 8076586
references.citation: Nature. 2009 Sep 24;461(7263):489-94
references.pmid: 19779445
references.citation: Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):94-101
references.pmid: 14744739
references.citation: Fertil Steril. 2009 Nov;92(5):1532-5
references.pmid: 18930188
references.citation: Pharmacogenomics. 2012 Apr;13(6):699-707
references.pmid: 22515612
references.citation: Reprod Biomed Online. 2007 Mar;14(3):341-7
references.pmid: 17359589
references.citation: Mol Biol Rep. 2012 May;39(5):6343-51
references.pmid: 22318545
references.citation: Semin Reprod Med. 2004 Feb;22(1):5-9
references.pmid: 15083376
references.citation: J Steroid Biochem Mol Biol. 2012 Jan;128(1-2):69-75
references.pmid: 21939764
references.citation: J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):219-24
references.pmid: 14623514
references.citation: Cancer. 2003 Oct 1;98(7):1411-6
references.pmid: 14508827
references.citation: Obes Res. 2003 Apr;11(4):578-85
references.pmid: 12690088
references.citation: Mol Cell Biochem. 2008 Jul;314(1-2):25-35
references.pmid: 18483761
references.citation: Cancer Res. 2010 Jan 1;70(1):319-28
references.pmid: 20048079
references.citation: Indian J Med Res. 2014 Jan;139(1):27-65
references.pmid: 24604039
references.citation: Breast Cancer Res Treat. 2008 Nov;112(1):89-98
references.pmid: 18049890
references.citation: J Alzheimers Dis. 2012;28(3):601-12
references.pmid: 22057025
references.citation: J Cancer Res Clin Oncol. 2001 Feb;127(2):135-8
references.pmid: 11216915
references.citation: Int J Med Sci. 2008 Feb 07;5(1):29-35
references.pmid: 18274619
references.citation: J Natl Cancer Inst. 2004 Jun 16;96(12):936-45
references.pmid: 15199113
references.citation: Asian Pac J Cancer Prev. 2009 Jan-Mar;10(1):111-4
references.pmid: 19469636
references.citation: Clin Cancer Res. 2008 Feb 1;14(3):811-6
references.pmid: 18245543
references.citation: PLoS One. 2012;7(4):e34828
references.pmid: 22511967
references.citation: J Hum Genet. 2010 Mar;55(3):189-93
references.pmid: 20186154
references.citation: Int J Cancer. 2005 Aug 20;116(2):267-74
references.pmid: 15800924
references.citation: Cancer Res. 2007 Mar 1;67(5):1893-7
references.pmid: 17325027
references.citation: Indian J Hum Genet. 2011 Sep;17(3):164-8
references.pmid: 22345987
references.citation: Cancer Chemother Pharmacol. 2011 Nov;68(5):1263-71
references.pmid: 21442439
references.citation: Genet Test Mol Biomarkers. 2011 Jun;15(6):407-13
references.pmid: 21375401
references.citation: Adv Exp Med Biol. 2008;617:359-66
references.pmid: 18497059
references.citation: Breast Cancer Res. 2011 Jan 20;13(1):R8
references.pmid: 21251330
references.citation: Clin Cancer Res. 2001 Oct;7(10):3092-6
references.pmid: 11595700
references.citation: Cancer Res. 2005 Dec 1;65(23):11071-82
references.pmid: 16322257